Fact or Fiction? Test Your Knowledge of Bipolar Depression

Fact or Fiction? Test Your Knowledge of Bipolar Depression

On-Demand Webcast

Roger S. McIntyre, MD, FRCPC
Professor of Psychiatry and Pharmacology
Head, Mood Disorders Psychopharmacology Unit
University of Toronto, Toronto, Canada
Chairman and Executive Director
Brain and Cognition Discovery Foundation, Toronto, Canada
Director, Depression and Bipolar Support Alliance, Chicago, Illinois, USA
Professor and Nanshan Scholar
Guangzhou Medical University, Guangzhou, China
Adjunct Professor, College of Medicine
Korea University, Seoul, Republic of Korea

Jeffrey R. Strawn, MD, FAACAP 
Associate Professor of Psychiatry & Pediatrics 
Clinical Professor, Department of Psychiatry 
Department of Psychiatry & Behavioral Neuroscience
University of Cincinnati, Cincinnati, Ohio, USA

For full faculty bios, please call 609-371-1137.




Provided by North American Center for Continuing Medical Education, LLC, an HMP Company and CMEology.

For questions regarding this educational activity, please call 609-371-1137 or email info@naccme.com.


This activity is intended for psychiatrists, primary care physicians, psychologists, physician assistants, psychiatric nurses, and other healthcare professionals who seek to improve the care of patients with mental health disorders.


After completing this activity, participants should be able to:

  • Implement strategies for recognition and evidence-based treatment of bipolar depression in children and adolescents
  • Identify bipolar depression in older adults and formulate a treatment plan using current evidence
  • Employ strategies to diagnose and treat patients with bipolar depression and mixed features of hypomania or mania

To be eligible for documentation of credit, participants must participate in the full activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Release Date: 12/6/2019
Expiration Date: 12/6/2020
Estimated time to complete: 1.5 hours

For questions regarding this educational activity, please call 609-371-1137.



In support of improving patient care, this activity has been planned and implemented by North American Center for Continuing Medical Education (NACCME) and CMEology. NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.


NACCME designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 credit(s). PAs should only claim credit commensurate with the extent of their participation in the activity.


This continuing nursing education activity awards 1.5 contact hours.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.5 contact hours.


This continuing nursing educational activity awards up to 1.5 pharmacology hours.

CE INFORMATION: Psychologists

As a jointly accredited organization, North American Center for Continuing Medical Education, LLC (NACCME) is approved by the American Psychological Association to sponsor continuing education for psychologists. NACCME maintains responsibility for this program and its content. Variable credit for partial attendance may not be awarded. Full attendance is required for all CE activities.

Instructional Level: Advanced

CE Information: Social Workers (ASWB ACE)

NACCME is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. NACCME maintains responsibility for this course. Social workers completing this course receive 1.5 Intermediate continuing education credits.


 The planning committee comprises Roger McIntyre, MD, FRCPC, Jeffrey Strawn, MD, FAACAP, Andrew Penn, RN, MS, NP, CNS, APRN-BC, William Torrey, MD; Beth Goodwin, Rob Lowney, and Dana Ravyn, PhD, MPH, CMEology; Meaghan Benci, Chris Bolwell, Raquel Gaerlan, Jennifer Ilcyn, Mary Johnson, Randy Robbin, Horacio Rodriguez, and Kelly Sweeney, NACCME.

Independent Clinical Reviewer: 

William C. Torrey, MD

Professor and Vice Chair for Clinical Services, Dartmouth’s Geisel School of Medicine, Dartmouth-Hitchcock, Lebanon, New Hampshire

Nurse Planner: 

Andrew Penn, RN, MS, NP, CNS, APRN-BC
Psychiatric Nurse Practitioner, Kaiser Permanente, Redwood City, CA; Assistant Clinical Professor, University of California, San Francisco, CA


 According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. 

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence. 

Dr. McIntyre: Consultant/Speaker for Allergan, Janssen, Lundbeck, Minerva, Neurocrine Biosciences, Inc., Otsuka America Pharmaceutical, Inc., Pfizer Inc., Purdue, Shire, Sunovion Pharmaceuticals Inc., Takeda Pharmaceutical Company; Research/Grant Support from CIHR/GACD/Chinese National Natural Research Foundation, Stanley Medical Research Institute. 

Dr. Strawn: Consultant/Advisor for Myriad Genetics; Research/Grant Support from Allergan, Myriad Genetics (material support), NIMH/NIEHS/NICHD, Neuronetics, Otsuka, Yung Family Foundation; Royalty/Patent Holder for Springer Publishing. 

Mr. Penn and Dr. Torrey disclosed no relevant financial relationships with any commercial interests. 

Ms. Benci, Ms. Gaerlan, Ms. Ilcyn, Mrs. Johnson, Mr. Robbin, Mr. Rodriguez, and Ms. Sweeney; Ms. Goodwin, Mr. Lowney, and Dr. Ravyn disclosed no relevant financial relationships with any commercial interests. 

Chris Bolwell is a shareholder of GlaxoSmithKline. GlaxoSmithKline is not supporting this activity, nor does any content relate to their product/service.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations. 

Off-label/unapproved uses of drugs and/or devices will be disclosed prior to the start of the symposium.


This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the Food and Drug Administration (FDA) of the United States or European Medicines Agency (EMA). Participants are encouraged to consult the EMA-approved or FDA-approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed in this document are the opinions of the presenters and do not necessarily reflect the opinions of Imedex, LLC and/or NACCME, LLC.


The evaluation is accessible after the activity via a PC (Windows 7 or newer) or Mac (Mac OS 10.6 or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.


North American Center for Continuing Medical Education (NACCME) complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137


NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint providers. NACCME and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2019 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.


Supported by an educational grant from Sunovion Pharmaceuticals Inc.